この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2001/4/301 分で読めます
Abbott Laboratories’ Sarafloxacin for Poultry; Withdrawal of Approval of NADAs
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of two new animal drug applications (NADAs) sponsored by Abbott Laboratories. The NADAs provide for use of sarafloxacin to treat poultry. In a final rule published elsewhere in this issue of the Federal Register , FDA is amending the animal drug regulations by removing the portions reflecting approval of these NADAs.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →